Evaluation of Sulfated Α-Glucans from Poria Cocos Mycelia As Potential Antitumor Agent

Qilin Huang,Lina Zhang,Peter C. K. Cheung,Xinti Tan
DOI: https://doi.org/10.1016/j.carbpol.2005.12.001
IF: 10.723
2006-01-01
Carbohydrate Polymers
Abstract:Six water-soluble sulfated derivatives (S1–S6) having molecular mass (Mw) from 2.65×104 to 14.5×104 were synthesized from the corresponding fractions of water-insoluble (1→3)-α-d-glucan (Pi-PCM3-I) isolated from pilot-scale product of Poria cocos mycelia. All sulfated derivatives had markedly higher antitumor activities in vivo (Sarcoma 180 solid tumor inoculated on BALB/c mice) as well as in vitro against human hepatoma cell HepG2 and S-180 tumor cell compared with the native non-sulfated (1→3)-α-d-glucan, and showed much lower toxicity than 5-Fu. Interestingly, the sulfated derivatives having moderate Mw exhibited more pronounced inhibition ratio, indicating the effect of Mw on bioactivities for the sulfated α-glucans. Using the fluorescence microscopy with Propidium iodide (PI)/Hoechst33342 staining, the mechanism involved in sulfated α-glucan-induced HepG2 cell apoptosis and necrosis was assessed morphologically. The results revealed that the sulfated derivative induced time-dependent increases in apoptosis (p<0.05). In view of immunohistochemical assays, the sulfated derivative can accelerate apoptosis in S-180 tumor cell by up-regulation of Bax (pro-apoptosis) and down-regulation of Bcl-2 (anti-apoptosis). A low Bcl-2:Bax ratio (0.27, p<0.05) caused by high Bax expression (50.3%, p<0.05) with low Bcl-2 (13.7%, p<0.05) indicated that the sulfated derivative had good therapeutic effect on tumor cell and the potential of clinical application as a chemtherapeutic agent.
What problem does this paper attempt to address?